Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population
Siang Ing Lee1, Mitesh Patel1, Christopher M Jones1
1School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, UK.
Insights
Cardiovascular disease (CVD) poses a significant threat to individuals with type 1 diabetes mellitus (T1D). Current management strategies lack specific evidence for T1D patients, especially older adults, highlighting an urgent need for targeted research.
Area of Science:
- Cardiology
- Endocrinology
- Geriatrics
Background:
- Cardiovascular disease (CVD) is a primary cause of death in type 1 diabetes mellitus (T1D).
- Existing research often extrapolates data from type 2 diabetes (T2D) or the general population, overlooking critical differences in T1D pathology and demographics.
- Increasing life expectancy exposes T1D patients to age-related cardiovascular (CV) risk factors.
Purpose of the Study:
- To review the current literature on CVD in T1D patients.
- To assess CVD prevalence, risk management, and potential biomarkers specifically within the T1D population.
- To evaluate the inclusion of older T1D patients (aged >65) in existing studies and discuss their CV risk management.
Main Methods:
- Systematic literature review of studies focusing on CVD in T1D.
- Analysis of data concerning CVD prevalence and risk factor management in T1D.
- Examination of research including older T1D populations and their specific management strategies.
Main Results:
- Significant CVD burden observed in T1D patients.
- Inadequate management of CV risk factors in this population.
- Limited evidence base for therapeutic CV risk management tailored to T1D, particularly in older adults.
Conclusions:
- There is a substantial CVD burden in T1D patients with suboptimal risk factor management.
- A critical gap exists in evidence-based therapeutic strategies for CVD risk in T1D, especially for the aging demographic.
- Further research is essential to explore the risks and benefits of CVD management interventions in older T1D patients.
Abstract:
Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes mellitus (T1D). However, evidence of its risks and management is often extrapolated from studies in type 2 diabetic (T2D) patients or the general population. This approach is unsatisfactory given that the underlying pathology, demographics and natural history of the disease differ between T1D and T2D. Furthermore, with a rising life expectancy, a greater number of T1D patients are exposed to the cardiovascular (CV) risk factors associated with an ageing population. The aim of this review is to examine the existing literature around CVD in T1D. We pay particular attention to CVD prevalence, how well we manage risk, potential biomarkers, and whether the studies included the older aged patients (defined as aged over 65). We also discuss approaches to the management of CV risk in the older aged. The available data suggest a significant CVD burden in patients with T1D and poor management of CV risk factors. This is underpinned by a poor evidence base for therapeutic management of CV risk specifically for patients with T1D, and in the most relevant population - the older aged patients. We would suggest that important areas remain to be addressed, particularly exploring the risks and benefits of therapeutic approaches to CVD management in the older aged.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction

